Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
نویسندگان
چکیده
منابع مشابه
Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
Nutrigenomics is a relatively new branch of nutrition science, which aim is to study the impact of the foods we eat on the function of our genes. Hepatosteatosis is strongly associated with hepatitis C virus infection, which is known to increase the risk of the disease progression and reduce the likelihood of responding to anti- virus treatment. It is well documented that hepatitis C virus can ...
متن کاملApplication of Nutrigenomics in HCV Hepatosteatosis: Impact of Food Factors-Gene Interactions
Nutrigenomics is a relatively new branch of nutrition science. Its goal is to study the impact upon on the function of our genes of the foods we eat. Hepatosteatosis is strongly associated with HCV infection. It seems firmly established that the hepatitis C virus can directly alter host cell cholesterol/lipid metabolism through lipogenic genes and thus induce hepatic steatosis. A combination of...
متن کاملImpact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study
OBJECTIVE Non-alcoholic fatty liver disease (NAFLD) is an established risk factor for diabetes, cardiovascular disease, antiviral treatment resistance, and progression of chronic hepatitis C virus (HCV) infection to fibrosis. Apolipoprotein-B 100 (ApoB-100) is a dyslipidemia marker and steatosis predictor. We assess the correlation between ApoB-100 and hepatosteatosis. METHODS This cross-sect...
متن کاملAntisense therapy for hepatitis C virus infection.
Background: The stability and propagation of hepatitis C virus (HCV) is dependent on a functional interaction between the HCV genome and liver-expressed microRNA-122 (miR-122). Miravirsen is a locked nucleic acid-modified DNA phosphorothioate antisense oligonucleotide that sequesters mature miR-122 in a highly stable heteroduplex, thereby inhibiting its function. Methods: In this phase 2a study...
متن کاملHepatitis C virus therapy update 2013.
PURPOSE OF REVIEW We review here the recent literature regarding hepatitis C virus (HCV) therapy through January 2013. We discuss current therapies, targets for new therapies, and what might be expected in this rapidly changing field. RECENT FINDINGS Boceprevir-based and telaprevir-based triple therapy with pegylated interferon and ribavirin marked the beginning of a new era in HCV therapy fo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Gastroenterology
سال: 2010
ISSN: 1471-230X
DOI: 10.1186/1471-230x-10-49